Free Trial

The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Soros Fund Management LLC

Cooper Companies logo with Medical background

Soros Fund Management LLC grew its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 29.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 225,930 shares of the medical device company's stock after buying an additional 50,930 shares during the quarter. Soros Fund Management LLC owned 0.11% of Cooper Companies worth $20,770,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Byrne Asset Management LLC purchased a new position in Cooper Companies during the fourth quarter worth approximately $33,000. OFI Invest Asset Management purchased a new stake in Cooper Companies in the 4th quarter worth $34,000. New Age Alpha Advisors LLC acquired a new position in Cooper Companies during the fourth quarter worth $38,000. Covestor Ltd lifted its holdings in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares in the last quarter. Finally, West Financial Advisors LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at about $49,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Trading Up 1.4 %

COO stock traded up $1.16 during midday trading on Friday, hitting $82.30. 1,708,555 shares of the company's stock were exchanged, compared to its average volume of 1,432,746. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $16.46 billion, a PE ratio of 42.21, a P/E/G ratio of 2.25 and a beta of 1.08. The business has a 50-day simple moving average of $81.44 and a two-hundred day simple moving average of $91.79.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. On average, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. BNP Paribas upgraded Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Piper Sandler reissued an "overweight" rating and issued a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Robert W. Baird decreased their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. Finally, Citigroup lowered their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $110.25.

View Our Latest Research Report on Cooper Companies

About Cooper Companies

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Read More

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines